1
Clinical Trials associated with CAR19-BCMA CAR-T Cells(Affiliated Hospital to Academy of Military Medical Sciences) / Not yet recruitingEarly Phase 1IIT A Clinical Study on the Safety and Efficacy of CAR19-BCMA Dual-target CAR-T Cell Therapy for Relapsed/Refractory Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation
This is a single arm study to evaluate the safety and efficacy of CAR19BCMA CAR-T cells in the treatment of relapsed/refractory CD19/BCMA positive plasma cell neoplasms and lymphomas/leukemias with plasmacytic differentiation.
100 Clinical Results associated with CAR19-BCMA CAR-T Cells(Affiliated Hospital to Academy of Military Medical Sciences)
100 Translational Medicine associated with CAR19-BCMA CAR-T Cells(Affiliated Hospital to Academy of Military Medical Sciences)
100 Patents (Medical) associated with CAR19-BCMA CAR-T Cells(Affiliated Hospital to Academy of Military Medical Sciences)
100 Deals associated with CAR19-BCMA CAR-T Cells(Affiliated Hospital to Academy of Military Medical Sciences)